Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE (NO-ASPIRATE)

July 23, 2019 updated by: University of Central Florida
Insertion of a breathing tube to enable treatment with mechanical ventilation (respirator) is often associated with complications, such as infection and lung injury. Leakage of secretions around the breathing tube (microaspiration) is a major factor leading to complications. The investigators propose that a standardized, enhanced oral suction protocol will be effective in reducing microaspiration and harms associated with mechanical ventilation. The investigators hypothesize that those randomized to the enhanced oral suction protocol will have less microaspiration and other ventilator-associated conditions than those in the usual care, standard suction group.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

513

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Orlando, Florida, United States, 32806
        • Orlando Regional Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older
  • orally intubated with endotracheal tube and treated with mechanical ventilation
  • 24 hours or less since intubation
  • expected to be intubated for at least 36 hours after enrollment

Exclusion Criteria:

  • documented aspiration at time of intubation
  • intubation to treat known aspiration
  • treatment with rescue mechanical ventilation therapies (oscillator)
  • re-intubation
  • contraindications to receiving the intervention (e.g., oral injuries)
  • history of lung or head/neck cancers that may produce amylase in the lungs
  • history of disease that affects saliva production (e.g., Sjögren's syndrome)
  • prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Enhanced oral suction
Deep oropharyngeal suction with catheter
Deep oropharyngeal suction with catheter every 4 hours
Sham Comparator: Usual Care Oral Suction
Oropharyngeal suction with suction swab
Oral suction with suction swab every 4 hours

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microaspiration as Measured by Tracheal Amylase
Time Frame: Every 12 hours up to 14 days
Specimens will be obtained every 12 hours for up to 14 days or subject no longer meets inclusion (e.g., extubation, tracheostomy, etc.); tracheal amylase measured in U/L.
Every 12 hours up to 14 days
Microaspiration as Measured by Percentage of Tracheal Specimens Positive for Amylase Per Participant
Time Frame: Every 12 hours up to 14 days
Specimens will be obtained every 12 hours for up to 14 days or subject no longer meets inclusion criteria
Every 12 hours up to 14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilator-Associated Condition (VAC) Rate
Time Frame: VAC assessed for 2 days beyond last intervention; mean 5.4 days
VAC rate was calculated between control and intervention groups using the Centers for Disease Control and Prevention (2013) criteria.
VAC assessed for 2 days beyond last intervention; mean 5.4 days
Time to VAC
Time Frame: VAC was assessed for two days beyond the last intervention; mean 5.4 days
VAC was assessed for two days beyond the last intervention; mean 5.4 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tracheal to Oral Ratio of Amylase
Time Frame: Every 12 hours up to 14 days
The ratio of the tracheal value to the oral value of amylase for each paired sample was calculated (ratio included baseline specimen collected).
Every 12 hours up to 14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mary L Sole, PhD, Univesity of Central Florida

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2014

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

October 15, 2014

First Submitted That Met QC Criteria

November 4, 2014

First Posted (Estimate)

November 5, 2014

Study Record Updates

Last Update Posted (Actual)

August 15, 2019

Last Update Submitted That Met QC Criteria

July 23, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 1R01NR014508-01A1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on Enhanced oropharyngeal suction

3
Subscribe